|
TL12: Biomarkers for Rare Events
*Samir Lababidi, FDA Keywords: Biomarkers, Rare Events, Safety Assessing safety in clinical trials with rare events can be challenging. With the rich literature of biomarkers over the last several years, how do biomarkers help in improving safety evaluation? What are the key methodological issues in using biomarkers for clinical trials with rare events?
|
Key Dates
-
November 1 - December 17, 2013
Online proposal submission for a session, short course and Town Hall Open -
January 6 - March 11, 2014
Online proposal submission for Roundtables Open -
April 30 - May 28, 2014
Abstract Submission Open -
June 4, 2014
Online Registration Opens -
August 8 - August 22, 2014
Invited Abstract Editing -
August 11, 2014
Short Course materials due from Instructors -
September 1, 2014
Housing Deadline -
September 15, 2014
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 22 - September 24, 2014
Marriott Wardman Park, Washington, DC
